VENUSREM
Start SIP
Invest Now
Start SIP in VENUSREM
Performance
- Low
- ₹731
- High
- ₹772
- 52 Week Low
- ₹278
- 52 Week High
- ₹840
- Open Price₹749
- Previous Close₹755
- Volume17,156
- 50 DMA₹731.27
- 100 DMA₹665.95
- 200 DMA₹573.67
Investment Returns
- Over 1 Month + 5.58%
- Over 3 Month + 43.46%
- Over 6 Month + 60.74%
- Over 1 Year + 143.01%
Smart Investing Starts Here Start SIP with Venus Remedies for Steady Growth!
Venus Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.3
- PEG Ratio
- 0.1
- Market Cap Cr
- 1,018
- P/B Ratio
- 1.7
- Average True Range
- 44.65
- EPS
- 57.09
- Dividend Yield
- 0
- MACD Signal
- 4.51
- RSI
- 51.62
- MFI
- 62.04
Venus Remedies Financials
Venus Remedies Technicals
EMA & SMA
Current Price
₹761.85
+
6.45
(0.85%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹756.30
- 50 Day
- ₹731.27
- 100 Day
- ₹665.95
- 200 Day
- ₹573.67
Resistance and Support
755.03
- R3 819.57
- R2 795.78
- R1 778.82
- S1 738.07
- S2 714.28
- S3 697.32
Venus Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-29 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-10 | Quarterly Results | |
| 2025-08-01 | Quarterly Results | |
| 2025-07-08 | Others | Inter-alia, to consider 1. Notice of 36th Annual General Meeting. 2. Boards Report for Financial Year 2024-2025. 3. Other business matters. |
| 2025-05-26 | Audited Results |
Venus Remedies F&O
About Venus Remedies
- NSE Symbol
- VENUSREM
- BSE Symbol
- 526953
- Chairman & Managing Director
- Mr. Pawan Chaudhary
- ISIN
- INE411B01019
Similar Stocks to Venus Remedies
Venus Remedies FAQs
Venus Remedies share price is ₹761 As on 13 February, 2026 | 03:22
The Market Cap of Venus Remedies is ₹1018.4 Cr As on 13 February, 2026 | 03:22
The P/E ratio of Venus Remedies is 13.3 As on 13 February, 2026 | 03:22
The PB ratio of Venus Remedies is 1.7 As on 13 February, 2026 | 03:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.